Showing results (141-150 of 815) with videos related to
Sort By:
Pageof 82
Plos One|April 24, 2020
Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA projectAnders Helander, Matilda Bäckberg, Olof BeckJournal of Medical Screening|May 8, 2014
Effect of a pre-screening survey on attendance in colorectal cancer screening: a double-randomized study in FinlandSanni Helander, Matti Hakama, Nea MalilaJournal of Chromatography|September 2, 1992
Determination of urinary 5-hydroxytryptophol by high-performance liquid chromatography with electrochemical detectionA Helander, O Beck, S BorgApplied Ergonomics|December 1, 1990
Effect of work-rest schedules on spinal shrinkage in the sedentary workerM G Helander, L A QuanceAlcohol and Alcoholism (Oxford, Oxfordshire)|October 19, 2007
Evaluation of a new immunoassay for urinary ethyl glucuronide testingMichael Böttcher, Olof Beck, Anders HelanderAlcohol and Alcoholism (Oxford, Oxfordshire)|June 14, 2012
Monitoring of the alcohol biomarkers PEth, CDT and EtG/EtS in an outpatient treatment settingAnders Helander, Oszkár Péter, Yufang ZhengDrug Testing and Analysis|April 11, 2024
Alternative routine for reporting chiral amphetamine test results in assessment of attention-deficit/hyperactivity disorder medication: experiences from 2013 to 2023Anders Helander, Annika Andersson, Tomas VillénClinical Toxicology (Philadelphia, Pa.)|September 2, 2014
MT-45, a new psychoactive substance associated with hearing loss and unconsciousnessA Helander, M Bäckberg, O BeckJournal of Clinical Apheresis|February 25, 2021
Pediatric double positive anti-glomerular basement membrane antibody and anti-neutrophil cytoplasmic antibody glomerulonephritis-A case report with review of literatureLouise Helander, Melisha Hanna, Kyle AnnenApplied Ergonomics|September 1, 1984
An overview of standards and guidelines for visual display terminalsM G Helander, B A RuppPageof 82